Nifty
Sensex
:
:
15763.05
52586.84
-15.40 (-0.10%)
-66.23 (-0.13%)

Pharmaceuticals & Drugs - Global

Rating :
57/99

BSE: 532331 | NSE: AJANTPHARM

2292.10
30-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  2385.00
  •  2389.90
  •  2251.10
  •  2394.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  184136
  •  4264.57
  •  2435.00
  •  1424.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 19,807.99
  • 29.14
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 19,600.07
  • 0.42%
  • 6.25

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.34%
  • 0.11%
  • 7.43%
  • FII
  • DII
  • Others
  • 8.94%
  • 11.47%
  • 1.71%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.61
  • 7.82
  • 12.03

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.43
  • 7.77
  • 12.01

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.81
  • 5.23
  • 19.11

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.68
  • 25.03
  • 24.11

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.65
  • 5.99
  • 4.55

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.64
  • 16.95
  • 15.30

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
747.99
668.20
11.94%
756.84
681.96
10.98%
748.74
651.21
14.98%
715.91
642.76
11.38%
Expenses
527.78
444.98
18.61%
497.43
530.62
-6.25%
507.06
465.24
8.99%
441.66
465.12
-5.04%
EBITDA
220.21
223.22
-1.35%
259.41
151.34
71.41%
241.68
185.97
29.96%
274.25
177.64
54.39%
EBIDTM
29.44%
33.41%
34.28%
22.19%
32.28%
28.56%
38.31%
27.64%
Other Income
32.63
13.12
148.70%
2.53
56.69
-95.54%
5.48
14.64
-62.57%
4.85
13.22
-63.31%
Interest
1.51
1.63
-7.36%
2.56
3.62
-29.28%
2.55
1.57
62.42%
1.53
4.93
-68.97%
Depreciation
30.88
28.02
10.21%
30.60
26.04
17.51%
29.14
23.60
23.47%
28.33
23.30
21.59%
PBT
220.45
206.69
6.66%
228.78
175.86
30.09%
215.47
175.10
23.06%
249.24
161.56
54.27%
Tax
46.70
58.93
-20.75%
69.52
46.70
48.87%
38.84
67.55
-42.50%
79.02
45.20
74.82%
PAT
173.75
147.76
17.59%
159.26
129.16
23.30%
176.63
107.55
64.23%
170.22
116.36
46.29%
PATM
23.23%
22.11%
21.04%
18.94%
23.59%
16.52%
23.78%
18.10%
EPS
19.98
16.85
18.58%
18.32
14.73
24.37%
20.31
12.26
65.66%
19.41
13.27
46.27%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
2,969.48
2,889.69
2,587.87
2,055.37
2,125.76
1,983.26
1,733.98
1,473.56
1,208.34
930.84
677.39
Net Sales Growth
12.30%
11.66%
25.91%
-3.31%
7.19%
14.38%
17.67%
21.95%
29.81%
37.42%
 
Cost Of Goods Sold
663.61
514.99
537.75
295.72
317.35
322.58
317.33
290.33
283.98
250.11
187.93
Gross Profit
2,305.87
2,374.70
2,050.12
1,759.65
1,808.41
1,660.68
1,416.65
1,183.23
924.36
680.73
489.46
GP Margin
77.65%
82.18%
79.22%
85.61%
85.07%
83.73%
81.70%
80.30%
76.50%
73.13%
72.26%
Total Expenditure
1,973.93
1,891.13
1,904.55
1,488.94
1,467.37
1,296.38
1,146.92
968.33
839.59
706.35
545.36
Power & Fuel Cost
-
43.70
38.88
32.65
27.42
18.70
15.49
12.91
11.20
10.25
7.83
% Of Sales
-
1.51%
1.50%
1.59%
1.29%
0.94%
0.89%
0.88%
0.93%
1.10%
1.16%
Employee Cost
-
548.25
485.59
430.71
376.47
295.42
256.64
200.58
156.97
123.18
93.84
% Of Sales
-
18.97%
18.76%
20.96%
17.71%
14.90%
14.80%
13.61%
12.99%
13.23%
13.85%
Manufacturing Exp.
-
226.20
204.81
174.78
215.80
192.70
174.40
130.81
96.29
81.76
60.60
% Of Sales
-
7.83%
7.91%
8.50%
10.15%
9.72%
10.06%
8.88%
7.97%
8.78%
8.95%
General & Admin Exp.
-
131.92
159.49
149.90
131.92
92.02
66.24
50.99
47.40
37.02
33.88
% Of Sales
-
4.57%
6.16%
7.29%
6.21%
4.64%
3.82%
3.46%
3.92%
3.98%
5.00%
Selling & Distn. Exp.
-
374.73
413.70
320.99
306.30
270.92
245.92
233.96
201.57
169.99
131.40
% Of Sales
-
12.97%
15.99%
15.62%
14.41%
13.66%
14.18%
15.88%
16.68%
18.26%
19.40%
Miscellaneous Exp.
-
51.34
64.33
84.19
92.11
104.04
70.90
48.75
42.18
34.04
131.40
% Of Sales
-
1.78%
2.49%
4.10%
4.33%
5.25%
4.09%
3.31%
3.49%
3.66%
4.41%
EBITDA
995.55
998.56
683.32
566.43
658.39
686.88
587.06
505.23
368.75
224.49
132.03
EBITDA Margin
33.53%
34.56%
26.40%
27.56%
30.97%
34.63%
33.86%
34.29%
30.52%
24.12%
19.49%
Other Income
45.49
25.98
92.19
21.08
24.16
23.86
21.15
16.80
13.71
5.60
6.22
Interest
8.15
8.27
11.91
1.16
0.41
1.36
4.89
5.92
8.73
19.13
15.43
Depreciation
118.95
116.09
95.71
72.08
59.59
61.21
44.43
51.64
43.88
34.17
31.87
PBT
913.94
900.18
667.89
514.27
622.55
648.17
558.89
464.47
329.85
176.79
90.95
Tax
234.08
246.31
196.27
127.30
153.91
141.34
143.28
146.15
95.97
64.68
13.69
Tax Rate
25.61%
27.36%
29.56%
24.75%
24.72%
21.81%
25.64%
32.05%
29.10%
36.59%
15.05%
PAT
679.86
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
112.11
77.26
PAT before Minority Interest
679.86
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
112.11
77.26
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
22.89%
22.63%
18.07%
18.83%
22.05%
25.56%
23.97%
21.03%
19.36%
12.04%
11.41%
PAT Growth
35.75%
39.81%
20.86%
-17.43%
-7.54%
21.95%
34.13%
32.49%
108.62%
45.11%
 
EPS
78.60
75.59
54.07
44.74
54.18
58.59
48.05
35.82
27.04
12.96
8.93

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
2,995.63
2,598.87
2,245.21
2,041.37
1,567.69
1,190.86
841.09
593.31
393.43
298.03
Share Capital
17.39
17.54
17.54
17.69
17.69
17.69
17.68
17.67
11.80
11.80
Total Reserves
2,977.70
2,580.86
2,226.57
2,022.05
1,550.00
1,173.17
822.98
575.06
381.13
286.23
Non-Current Liabilities
274.55
227.61
162.23
38.56
8.90
28.63
55.67
80.62
102.46
100.59
Secured Loans
1.60
0.74
0.66
1.01
1.04
5.79
23.31
41.53
57.57
62.09
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
9.08
9.94
10.77
15.76
14.00
Long Term Provisions
208.12
155.01
134.15
13.16
4.88
2.59
4.76
2.83
2.98
4.91
Current Liabilities
838.82
745.53
498.35
346.05
246.66
259.89
249.59
275.42
222.34
250.19
Trade Payables
373.86
362.34
225.18
249.63
178.18
145.57
109.06
124.54
131.71
101.32
Other Current Liabilities
214.14
180.12
111.45
63.95
46.33
56.72
58.33
47.63
19.45
43.15
Short Term Borrowings
0.00
42.85
33.34
0.00
0.00
46.25
17.90
60.55
51.26
95.27
Short Term Provisions
250.82
160.22
128.38
32.47
22.15
11.35
64.30
42.70
19.92
10.45
Total Liabilities
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81
Net Block
1,541.11
1,472.14
1,168.35
1,052.66
589.17
450.74
288.09
279.39
272.56
246.12
Gross Block
2,140.78
1,976.15
1,578.96
1,417.23
894.94
715.73
549.85
492.00
438.49
378.01
Accumulated Depreciation
599.67
504.01
410.61
364.57
305.77
264.99
261.76
212.61
165.93
131.89
Non Current Assets
1,891.22
1,790.94
1,605.27
1,202.36
972.65
716.11
512.94
429.30
349.21
309.13
Capital Work in Progress
108.19
131.86
261.61
61.33
254.22
198.91
170.20
93.55
12.49
2.51
Non Current Investment
0.00
12.28
22.87
7.58
0.00
0.00
40.04
8.46
8.46
8.46
Long Term Loans & Adv.
230.74
164.20
148.36
76.79
41.88
21.29
9.34
39.15
48.61
50.75
Other Non Current Assets
11.18
10.46
4.08
4.00
2.34
4.28
5.27
8.75
7.09
1.29
Current Assets
2,217.78
1,781.07
1,300.52
1,223.62
850.60
763.27
633.41
520.05
369.02
339.68
Current Investments
175.67
67.14
64.74
182.38
181.56
76.78
19.46
55.00
0.00
0.00
Inventories
766.47
495.68
435.71
350.63
211.02
204.58
159.03
155.40
147.60
167.80
Sundry Debtors
738.43
775.30
459.48
459.79
323.15
372.35
258.76
202.22
150.47
141.00
Cash & Bank
209.61
205.25
100.51
93.09
69.95
43.37
136.76
60.39
46.23
11.48
Other Current Assets
327.60
69.02
96.63
114.62
64.92
66.19
59.40
47.04
24.72
19.40
Short Term Loans & Adv.
223.45
168.68
143.45
23.11
56.29
59.39
47.43
43.66
20.72
15.92
Net Current Assets
1,378.96
1,035.54
802.17
877.57
603.94
503.38
383.82
244.63
146.68
89.49
Total Assets
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
576.31
456.77
374.51
281.12
609.29
326.14
279.42
212.42
234.27
70.35
PBT
900.18
663.97
514.27
622.56
648.17
558.90
456.01
329.85
163.51
90.96
Adjustment
115.27
70.79
61.93
52.48
86.33
53.07
51.21
50.82
65.28
51.35
Changes in Working Capital
-208.75
-123.16
-83.46
-254.32
25.88
-124.34
-81.69
-74.52
38.60
-54.53
Cash after chg. in Working capital
806.70
611.60
492.74
420.72
760.38
487.63
425.53
306.15
267.39
87.78
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-230.39
-154.83
-118.23
-139.60
-151.09
-161.49
-146.11
-93.73
-33.12
-17.43
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-282.39
-224.40
-222.78
-256.11
-383.12
-209.07
-158.36
-187.80
-103.70
-53.07
Net Fixed Assets
-137.02
-255.91
-361.08
-327.21
-235.38
-197.00
-138.00
-120.60
-68.66
-46.30
Net Investments
-71.11
7.11
107.76
-1.82
-104.79
-17.41
2.22
-59.98
-1.81
0.00
Others
-74.26
24.40
30.54
72.92
-42.95
5.34
-22.58
-7.22
-33.23
-6.77
Cash from Financing Activity
-318.29
-128.63
-147.46
-0.20
-201.77
-117.32
-105.19
-20.13
-104.49
-12.84
Net Cash Inflow / Outflow
-24.37
103.74
4.27
24.81
24.40
-0.25
15.87
4.49
26.08
4.44
Opening Cash & Equivalents
202.36
95.16
90.64
65.83
41.42
41.67
38.62
34.13
8.05
3.61
Closing Cash & Equivalent
177.99
198.90
94.91
90.64
65.82
41.42
54.49
38.62
34.13
8.05

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
346.24
297.80
257.19
231.78
178.14
135.31
95.57
67.42
44.73
33.92
ROA
17.03%
14.44%
14.52%
22.06%
30.69%
31.66%
29.57%
28.05%
16.40%
13.20%
ROE
23.38%
19.32%
18.07%
25.98%
36.75%
40.92%
43.24%
47.47%
32.46%
29.34%
ROCE
32.20%
27.44%
23.84%
34.49%
45.74%
51.61%
56.43%
54.53%
38.62%
23.23%
Fixed Asset Turnover
1.40
1.46
1.37
1.84
2.49
2.76
2.85
2.61
2.29
1.98
Receivable days
95.60
87.08
81.62
67.06
63.41
65.84
56.64
52.93
56.78
65.22
Inventory Days
79.71
65.68
69.82
48.10
37.89
37.93
38.64
45.48
61.44
74.79
Payable days
67.55
59.55
63.24
57.26
50.30
41.91
46.38
59.31
61.76
59.93
Cash Conversion Cycle
107.77
93.21
88.21
57.90
51.01
61.86
48.91
39.10
56.46
80.09
Total Debt/Equity
0.00
0.02
0.02
0.00
0.00
0.07
0.09
0.22
0.32
0.67
Interest Cover
109.85
56.75
444.34
1519.41
477.60
115.29
78.03
38.78
10.24
6.89

News Update:


  • Ajanta Pharma earmarks Rs 250 crore capex for FY22
    10th May 2021, 09:57 AM

    The company is likely to use the same towards maintenance and some new expansions for the corporate office

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.